Schizophrenia: Do we really need placebo-controlled studies?
- 10 December 1998
- journal article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 8 (4) , 279-286
- https://doi.org/10.1016/s0924-977x(97)00081-3
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Clinical relevance of response and improvement in psychopharmacologyEuropean Neuropsychopharmacology, 1995
- Risperidone in the treatment of negative symptoms of schizophreniaInternational Clinical Psychopharmacology, 1995
- Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus HaloperidolThe British Journal of Psychiatry, 1995
- The Continuing Unethical Use of Placebo ControlsNew England Journal of Medicine, 1994
- Negative symptoms in schizophrenia: considerations for clinical trialsPsychopharmacology, 1994
- Evidence-Based MedicineJAMA, 1992
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988